Article
Citigroup Maintains Buy on Bio-Techne, Raises Price Target to $80
Citigroup analyst Patrick Donnelly maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $70 to $80.
Comments
- No comments yet. Be the first to comment!